Yasushi Hara Selected Research

Hypophysectomy

1/2019	Hyperadrenocorticism Caused by a Pituitary Ganglioglioma in a Dog.
3/2010	Hypophysectomy for a dog with coexisting Cushing's disease and diabetes mellitus.
1/2009	Coexistence of corticotroph adenoma and thyrotroph hyperplasia in a dog.
5/2008	Cushing's disease complicated with thrombosis in a dog.
1/2006	Functional and morphological changes in the hypothalamus-pituitary posterior lobe system after hypophysectomy in the dog.
7/2003	Transsphenoidal hypophysectomy for four dogs with pituitary ACTH-producing adenoma.
1/2003	Prophylactic efficacy of desmopressin acetate for diabetes insipidus after hypophysectomy in the dog.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasushi Hara Research Topics

Disease

12	Neoplasms (Cancer) 07/2022 - 09/2002
5	Adrenocortical Hyperfunction (Adrenal Gland Hyperfunction) 01/2022 - 07/2003
5	ACTH-Secreting Pituitary Adenoma 01/2020 - 08/2006
5	Pituitary ACTH Hypersecretion 04/2010 - 01/2009
4	Breast Neoplasms (Breast Cancer) 07/2022 - 01/2020
4	Osteoarthritis 09/2020 - 01/2013
4	Inflammation (Inflammations) 07/2019 - 06/2006
4	Intervertebral Disc Degeneration 01/2015 - 01/2008
3	Intervertebral Disc Displacement (Herniated Disc) 07/2020 - 03/2005
3	Wounds and Injuries (Trauma) 07/2012 - 01/2002
2	Rupture 07/2020 - 06/2006
2	Adenoma (Adenomas) 01/2020 - 07/2003
2	Carcinogenesis 01/2020 - 06/2011
2	Infections 07/2019 - 01/2018
2	Sepsis (Septicemia) 07/2019 - 07/2005
2	Spinal Cord Injuries (Spinal Cord Injury) 08/2016 - 02/2015
2	Hypertrophy 10/2015 - 08/2006
2	Ischemia 04/2008 - 12/2002
2	Diabetes Insipidus 01/2006 - 01/2003
2	Hip Dislocation 12/2005 - 10/2002
1	Triple Negative Breast Neoplasms 12/2021
1	Joint Instability (Joint Laxity) 09/2020
1	Pathologic Constriction (Stenosis) 04/2020
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2020
1	Hyperplasia 01/2020
1	Ganglioglioma 01/2019
1	B-Cell Leukemia (Leukemia, B Cell) 01/2019
1	Leukemia 01/2019
1	Melanoma (Melanoma, Malignant) 01/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017
1	Hyperuricemia 03/2016
1	Arthritis (Polyarthritis) 03/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2016
1	Muscular Dystrophies (Muscular Dystrophy) 01/2016
1	Muscular Diseases (Myopathy) 01/2016
1	Paraplegia (Spastic Paraplegia) 02/2015

Drug/Important Bio-Agent (IBA)

6	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2020 - 07/2003
4	CytokinesIBA 01/2013 - 12/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008 - 12/2002
4	Interleukin-6 (Interleukin 6)IBA 04/2008 - 12/2002
3	Small Interfering RNA (siRNA)IBA 07/2022 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2018
3	Hormones (Hormone)IBA 08/2018 - 07/2003
3	Proteoglycans (Proteoglycan)IBA 10/2015 - 03/2005
3	Matrix Metalloproteinases (MMPs)IBA 06/2006 - 03/2005
2	Aldehyde Dehydrogenase 1 FamilyIBA 07/2022 - 12/2021
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 01/2009
2	Trypan Blue FDA Link 12/2021 - 01/2020
2	3- (1,3- benzothiazol- 2- yl)- 4- (4- methoxyphenyl)but- 3- enoic acidIBA 12/2021 - 11/2018
2	Propofol (Diprivan)FDA LinkGeneric 07/2013 - 05/2003
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 04/2010 - 01/2009
2	Messenger RNA (mRNA)IBA 01/2009 - 07/2005
2	InterleukinsIBA 04/2008 - 12/2005
2	A73025IBA 06/2006 - 12/2005
2	Interleukin-1beta (Interleukin 1 beta)IBA 06/2006 - 12/2002
1	Phenobarbital (Luminal)FDA Link 07/2022
1	Corticotropin-Releasing HormoneIBA 01/2022
1	Atrial Natriuretic Factor (ANF)IBA 12/2021
1	Protein Kinase CIBA 12/2021
1	ClaudinsIBA 01/2021
1	CaspasesIBA 01/2020
1	Auranofin (Ridaura)FDA Link 01/2020
1	GSK 1363089IBA 01/2020
1	C-Reactive ProteinIBA 07/2019
1	Biomarkers (Surrogate Marker)IBA 07/2019
1	LipidsIBA 01/2019
1	Histones (Histone)IBA 01/2019
1	ChromatinIBA 01/2019
1	TransposasesIBA 01/2019
1	somatostatin receptor 5IBA 08/2018
1	somatostatin receptor 2IBA 08/2018
1	Melanocyte-Stimulating Hormones (MSH)IBA 08/2018
1	Dopamine Agonists (Dopamine Agonist)IBA 08/2018
1	Somatostatin Receptors (Somatostatin Receptor)IBA 08/2018
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 08/2018
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 08/2018
1	LigandsIBA 01/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Imatinib Mesylate (Gleevec)FDA Link 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Neuroprotective AgentsIBA 08/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2016
1	InflammasomesIBA 03/2016
1	Xanthine DehydrogenaseIBA 03/2016
1	Uric Acid (Urate)IBA 03/2016
1	CateninsIBA 01/2015
1	diquafosolIBA 10/2014

Therapy/Procedure

7	Hypophysectomy 01/2019 - 01/2003
5	Therapeutics 01/2013 - 07/2003
3	Osteotomy 09/2020 - 10/2002
3	Anesthesia 07/2013 - 01/2002
2	Surgical Decompression 07/2020 - 02/2015
2	General Anesthesia 01/2020 - 07/2013
1	Catheters 01/2022
1	Laminectomy 04/2020
1	Transplantation 08/2016
1	Denervation 01/2016
1	Analgesia 02/2015